Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Biology & Therapy|November 15, 2006
Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signalingAdda Grimberg, Carrie M Coleman, Zonggao Shi, et al.
The Biochemical Journal|October 15, 1994
A spectroscopic study of the mitochondrial transit peptide of rat malate dehydrogenaseL K MacLachlan, P I Haris, D G Reid, et al.
The Journal of Biological Chemistry|January 25, 2000
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expressionT K MacLachlan, K Somasundaram, M Sgagias, et al.
Human Gene Therapy|August 22, 2022
Regulatory Consideration for the Nonclinical Safety Assessment of Gene TherapiesJeffrey S Moffit, Diann L Blanset, Jessica L Lynch, et al.
Oncogene|December 22, 1999
BRCA1 signals ARF-dependent stabilization and coactivation of p53K Somasundaram, T K MacLachlan, T F Burns, et al.
The Journal of Biological Chemistry|August 22, 1997
A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activityA De Luca, T K MacLachlan, L Bagella, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 26, 2011
Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic miceMeghan M Flaherty, Timothy K MacLachlan, Misty Troutt, et al.
Biochimica Et Biophysica Acta|May 21, 1992
An electrophysiological and spectroscopic study of the properties and structure of biological calcium channels. Investigations of a model ion channelD G Reid, L K MacLachlan, C J Salter, et al.
Mabs|May 6, 2017
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal useFiona Sewell, Kathryn Chapman, Jessica Couch, et al.
Cancer Research|March 15, 1995
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancerF Bullrich, T K MacLachlan, N Sang, et al.
Pageof 5